The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis

• Status: Completed
• Trial end date: 2019-10-20
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of the work is to determine whether the use of immunomodulatory drugs could improve the reproductive of outcome of infertile patients who have autoimmune thyroiditis with positive autoimmune antibodies undergoing IVF-ET.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aljazeera Hospital
• Treatments: Aspirin; Calcium, Dietary; Ergocalciferols; Hydroxychloroquine; Selenium; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Infertility patients who have autoimmune thyroiditis With positive autoimmune thyroiditis and TSH level above 2 IU.

Exclusion Criteria:

• All patients who have other autoimmune diseases especially antiphospholipid syndrome, hepatitis c viral disease.

Patients who have any medical disorders ( eg. D.M. HTN .Epilepsy ….)